Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56

United States Fiscal year ends December CIK 0001819790 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$19.96M

$11.70M on a plan · $979.74K straight out of an exercise

Sold at will

$7.28M

23 of 59 sales

Net

−$19.96M

−$7.28M against sales at will